Student Publications

2023

Adaku N, Ostendorf BN, Mei W, Tavazoie SF.  2023.  Apolipoprotein E2 Stimulates Protein Synthesis and Promotes Melanoma Progression and Metastasis.. Cancer Res. 83(18):3013-3025.
2023
Qi J, Cheng W, Gao Z, Chen Y, Shipton ML, Furkert D, Chin AC, Riley AM, Fiedler D, Potter BVL et al..  2023.  Itraconazole inhibits endothelial cell migration by disrupting inositol pyrophosphate-dependent focal adhesion dynamics and cytoskeletal remodeling.. Biomed Pharmacother. 161:114449.
2023
Qi L, Iskols M, Shi D, Reddy P, Walker C, Lezgiyeva K, Voisin T, Pawlak M, Kuchroo VK, Chiu I et al..  2023.  A DRG genetic toolkit reveals molecular, morphological, and functional diversity of somatosensory neuron subtypes.. bioRxiv.
2023
Yamin R, Kao KS, MacDonald MR, Cantaert T, Rice CM, Ravetch JV, Bournazos S.  2023.  Human FcγRIIIa activation on splenic macrophages drives dengue pathogenesis in mice.. Nat Microbiol. 8(8):1468-1479.
2023
Yao P, Witte D, German A, Periyakoil P, Kim YEun, Gimonet H, Sulica L, Born H, Elemento O, Barnes J et al..  2023.  A deep learning pipeline for automated classification of vocal fold polyps in flexible laryngoscopy.. Eur Arch Otorhinolaryngol.
2023
Sziraki A, Lu Z, Lee J, Banyai G, Anderson S, Abdulraouf A, Metzner E, Liao A, Banfelder J, Epstein A et al..  2023.  A global view of aging and Alzheimer's pathogenesis-associated cell population dynamics and molecular signatures in human and mouse brains.. Nat Genet. 55(12):2104-2116.
2023
Persad S, Choo Z-N, Dien C, Sohail N, Masilionis I, Chaligne R, Nawy T, Brown CC, Sharma R, Pe'er I et al..  2023.  SEACells infers transcriptional and epigenomic cellular states from single-cell genomics data.. Nat Biotechnol.
2023
Lumaquin-Yin D, Montal E, Johns E, Baggiolini A, Huang T-H, Ma Y, LaPlante C, Suresh S, Studer L, White RM.  2023.  Lipid droplets are a metabolic vulnerability in melanoma.. Nat Commun. 14(1):3192.
2023
Gagne M, Flynn BJ, Honeycutt CCole, Flebbe DR, Andrew SF, Provost SJ, McCormick L, Van Ry A, McCarthy E, Todd J-PM et al..  2023.  RBD-based high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways.. bioRxiv.
2023